Clinical Trials Logo

Clinical Trial Details — Status: Unknown status

Administrative data

NCT number NCT01355341
Other study ID # ACE/HMP-01
Secondary ID
Status Unknown status
Phase Phase 2
First received May 16, 2011
Last updated May 17, 2011
Start date April 2010
Est. completion date December 2011

Study information

Verified date May 2011
Source Amai Charitable Trust
Contact PATANKAR B PATANKAR, MS.MCH
Phone 25434063
Email amaitrust@yahoo.co.in; suresh_iou@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

More specifically, the present invention relates to a 'Herbal Preparation' that is useful for

- Treatment of Renal calculi

- Reduction in the stone size & surface area

- The expulsion of stone

- Decreased need of Analgesic(Antiinflammatory Effect)

- Stops the recurrence and reformation of renal


Description:

1. Study duration 28 weeks

2. No. of Scheduled visits 8 visits

3. Study product Dose, Group one-:1capsule (of 500 mg) orally twice a day with meals for 24 weeks. Group two-:placebo1capsule (of 500 mg) orally twice a day with meals for 24 weeks.


Recruitment information / eligibility

Status Unknown status
Enrollment 84
Est. completion date December 2011
Est. primary completion date December 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 10 Years to 75 Years
Eligibility Inclusion Criteria:

- Age 10-75 years (Both inclusive)

- Patients with Renal calculi, diagnosis confirmed by plain X-ray KUB &/or ultrasound KUB/CT scan Abdomen

- Size of the calculi ranging from 04 mm -09 mm

- Able and willing to give written informed consent and comply with the requirements of the study protocol

- Patients of reproductive potential (males and females) and willing to use a reliable means of contraception (e.g hormonal contraceptive patch, intrauterine device and physical barrier) throughout study participation

- Patients will to cooperate & give consent for the trial& comes for regular follow up.

Exclusion Criteria:

- Patients having acute condition of renal calculi.

- Any systemic disease requiring other medications of surgery for calculus condition.

- Complicated cases of Renal Calculi requiring surgical condition.

- Chronic or current infectious disease such as but not limited to chronic renal infection including active urinary tract infection.Uncontrolled diabetes, hypertension, symptomatic congestive heart failure, unstable angina pectoris, myocardial infarction

- Any other urogenital disorders.

- Liver dysfunction, defined as total bilirubin more then 1.5 the upper limit of Normal, aspartate aminotransferase more then 2.5 upper limit of Normal, or alanine aminotransferase more then 2.5 upper limit of Normal,

- Kidney disease, including serum creatinine level more then 1.5 upper limit of Normal,

- Subjects on herbal supplements for stone disease (plant extracts preparations or herbal medicines etc.) within previous 3 months.

- Participated in another clinical drug trial within 3 months before recruitment.

- Pregnancy or breast feeding

- Evidence of significant uncontrolled concomitant disease which in the Investigator's opinion would preclude patient participation

- Currently active alcohol or drug abuse or history of alcohol or drug abuse within 24 weeks prior to baseline

- Patients with psychiatric illness or other condition that would limit compliance with study requirements

- Patients receiving or has received any investigational drug within 30 days before receiving the first dose of study medication

- Subjects who refuse to sign the informed consent document .

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
HERBMED PLUS
500 mg Twice day for 6 month with lunch and dinner.

Locations

Country Name City State
India AMAI Charitable Trust's ACE Hospital Pune Pune Maharashatra

Sponsors (1)

Lead Sponsor Collaborator
Amai Charitable Trust

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate the efficacy of "Herbmed plus"in patients with urinary calculi by assessing the reduction in the stone size & surface area/ or the expulsion of stone In 210 days
Secondary Reduction in the size of stone Reduction in the density of the stone Painless expulsion of the stone/fragments Reduction in pain Consumption of Analgesics In 210 days
See also
  Status Clinical Trial Phase
Recruiting NCT01450566 - Intraureteral Lidocaine for Post-Ureteroscopy Pain N/A
Recruiting NCT05701098 - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) N/A
Not yet recruiting NCT01008267 - Shockwave Lithotripsy (SWL) Under Selective, General Anesthesia. N/A
Completed NCT00250406 - Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation Phase 2
Recruiting NCT00169806 - Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis N/A
Not yet recruiting NCT02734914 - Suctioning Flexible Ureteroscopy With Intelligent Control of Renal Pelvic Pressure N/A
Completed NCT00169741 - Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC N/A
Completed NCT05972408 - Evaluation of Prevalence, Molecular and Genetic Backgrounds of Calcium-Based Stones Among Patients With Renal Calcular Disease in Mansoura Urology and Nephrology Center
Enrolling by invitation NCT02408211 - Preoperative Antibiotic PNL Study Phase 4
Completed NCT01437904 - A Pilot Study Assessing The Feasibility Of Outpatient Tubeless Percutaneous Nephrolithotomy (PCNL) N/A
Completed NCT00857090 - Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones Phase 1/Phase 2
Recruiting NCT05240170 - RIRS for Treatment of Stones in Congenital Anomalous Kidneys N/A
Completed NCT03112499 - The Effect of Three Endourological Procedures for the Management of Renal Calculi Regarding Acute Kidney Injury N/A
Recruiting NCT03206515 - The 18F Peel-way Sheath Versus the 18F Access Sheath With a Suction-evacuation Function MPCNL for the Management of 2-5cm Size Kidney Stones N/A
Completed NCT03344107 - Stent-related Symptoms Comparison: Polaris Loop vs Vortek Double-J Stents N/A
Recruiting NCT05077007 - Evaluation of Renal Damage After PCNL and ESWL Using Novel RNA Based Biomarkers N/A
Completed NCT03614247 - Cost-Effectiveness of Different Treatment Options for Lower Calyceal Stones N/A
Recruiting NCT05739812 - The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery N/A
Recruiting NCT05869890 - Ureteroscopic Laser Modality on Total Lasing Time and Total Energy in Patients With Large, Dense Renal Calculi N/A
Completed NCT00893282 - Clinical Evaluation of BackStop in Patients Undergoing Intraureteric Stone Lithotripsy N/A